Harneys advises on HK$400 million IPO of 160 Health International Limited
The company’s shares began trading on 17 September 2025 under stock code 2656. This IPO underscores the continued dynamism of Hong Kong’s equity markets and the capital-raising appetite within China’s healthtech and pharmaceutical sector.
160 Health is a leading digital healthcare integrated service provider in China, best known for its “Healthcare 160” platform, recognized as one of the largest digital healthcare and wellness service platforms in the country. The company delivers end-to-end digital healthcare and wellness solutions to a wide ecosystem that encompasses corporates, medical institutions, professionals, individual users, and third-party merchants—driving digital transformation across the healthcare value chain.
The Harneys team was led by Counsel Annie Lui and Legal Manager Jane Chan, and supported by Hong Kong Corporate Partner Raymond Ng and Paralegal Matt Ip. Shenwan Hongyuan Capital (H.K.) Limited and Zero2IPO Capital Limited acted as joint sponsors. Commenting on the listing, Raymond said: “We are delighted to have advised 160 Health on its successful Hong Kong IPO, further highlighting Harneys’ commitment and depth of expertise in guiding innovative Chinese healthcare businesses to international capital markets.”
Harneys’ Corporate team has a market-leading ECM practice with deep experience in capital raisings by offshore issuers, including IPOs and secondary offerings, rights issues, and equity-linked securities on all major stock exchanges worldwide.
